Scientists engineer CRISPR enzymes that evade the immune system
Broad Institute
JANUARY 9, 2025
Researchers at the Broad Institute of MIT and Harvard and Cyrus Biotechnology have now engineered two CRISPR nucleases, Cas9 and Cas12, to mask them from the immune system. The team identified protein sequences on each nuclease that trigger the immune system and used computational modeling to design new versions that evade immune recognition.
Let's personalize your content